Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1991;78:1112-1116
© 1991 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SMEGO, R. A.
Right arrow Articles by ASPERILLA, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SMEGO, R. A., Jr.
Right arrow Articles by ASPERILLA, M. O.

Use of Acyclovir for Varicella Pneumonia During Pregnancy

RAYMOND A. SMEGO, Jr., MD, MPH and MARIANITO O. ASPERILLA, MD

From the Section of Infectious Diseases, West Virginia University Health Sciences Center, Morgantown, West Virginia; and the Division of Infectious Diseases, Albany Medical College, Albany, New York

Abstract

Twenty-one cases (five new and 16 literature) of varicella pneumonia of pregnancy were retrospectively reviewed to evaluate the benefits and risks of intravenous acyclovir on maternal and fetal outcomes. All women were in their second (12 cases) or third (nine cases) trimester. Mean gestational ages at the onset of pneumonia and time of delivery were 27 and 36 weeks, respectively. Twelve patients required mechanical ventilation. The mean duration of treatment was 7 days. No definite adverse drug effects were noted. Three women (14%) died of uncontrolled infection or complications. Two infants died (whose mothers also died): One was stillborn at 34 weeks' gestation, and the other died from prematurity shortly after birth at 26 weeks. No child was born with features of congenital varicella syndrome, and none developed active perinatal varicella infection. Onset of pneumonia during the third trimester was a risk factor associated with fatal maternal outcome. Intravenous acyclovir may reduce maternal morbidity and mortality associated with varicella pneumonia occurring during pregnancy, and appears to be safe for the developing fetus when given during the latter trimesters.




This article has been cited by other articles:


Home page
Eur Respir JHome page
A.H. Mohsen and M. McKendrick
Varicella pneumonia in adults
Eur. Respir. J., May 1, 2003; 21(5): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
W S Lim, J T Macfarlane, and C L Colthorpe
Respiratory diseases in pregnancy {bullet} 2: Pneumonia and pregnancy
Thorax, May 1, 2001; 56(5): 398 - 405.
[Full Text]


Home page
Clin. Microbiol. Rev.Home page
M. A. Keller and E. R. Stiehm
Passive Immunity in Prevention and Treatment of Infectious Diseases
Clin. Microbiol. Rev., October 1, 2000; 13(4): 602 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American College of Obstetricians and Gynecologists.